Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
- 74 Volumes
- 745 Issues
- 7,646 Articles
- 27 Open Access
- 1971 - 2014 Available between
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
André J. Scheen (December 2014)
R&D Insight Report
Karly P. Garnock-Jones (December 2014)
To view the rest of this content please follow the download PDF link above.